EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing

Terezia Kurucova iD, Kamila Reblova iD, Pavlina Janovska iD, Jakub Pawel Porc iD, Veronika Navrkalova iD, Sarka Pavlova iD, Jitka Malcikova iD, Karla Plevova iD, Boris Tichy iD, Michael Doubek iD, Vitezslav Bryja iD, Jana Kotaskova iD und 1 weitere

Molecular Oncology · 2024

DOI: 10.1002/1878-0261.13663 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Oncology, 2024. Verfasst von Terezia Kurucova und 12 weiteren Autor:innen. Beteiligte Einrichtung: Central European Institute of Technology, Center of Molecular Medicine, Masaryk University, Brno, Czech Republic. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Single-Cell Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - Next Generation EU, Ministerstvo Zdravotnictví Ceské Republiky, Grantová Agentura České Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early identification of resistant cancer cells is currently a major challenge, as their expansion leads to refractoriness. To capture the dynamics of these cells, we made a comprehensive analysis of disease progression and treatment response in a chronic lymphocytic leukemia (CLL) patient using a combination of single‐cell and bulk genomic methods. At diagnosis, the patient presented with unfavorable genetic markers, including notch receptor 1 ( NOTCH1 ) mutation and loss(11q). The initial and subsequent treatment lines did not lead to a durable response and the patient developed refractory disease. Refractory CLL cells featured substantial dysregulation in B‐cell phenotypic markers such as human leukocyte antigen (HLA) genes, immunoglobulin (IG) genes, CD19 molecule ( CD19 ), membrane spanning 4‐domains A1 ( MS4A1 ; previously known as CD20), CD79a molecule ( CD79A ) and paired box 5 ( PAX5 ), indicating B‐cell de‐differentiation and disease transformation. We described the clonal evolution and characterized in detail two cell populations that emerged during the refractory disease phase, differing in the presence of high genomic complexity. In addition, we successfully tracked the cells with high genomic complexity back to the time before treatment, where they formed a rare subpopulation. We have confirmed that single‐cell RNA sequencing enables the characterization of refractory cells and the monitoring of their development over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellSingle-Cell AnalysisHumansDrug Resistance, NeoplasmSequence Analysis, RNAMale

Stichwörter der Autor:innen

CLLclonal evolutionrare subpopulationrefractorinesssingle‐cell RNA sequencing

Autor:innen und Institutionen

  • Central European Institute of Technology, Center of Molecular Medicine, Masaryk University, Brno, Czech Republic.
  • Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic.
  • Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic.

ORCID-Profile: Terezia Kurucova, Kamila Reblova, Pavlina Janovska, Jakub Pawel Porc, Veronika Navrkalova, Sarka Pavlova, Jitka Malcikova, Karla Plevova, Boris Tichy, Michael Doubek, Vitezslav Bryja, Jana Kotaskova, Sarka Pospisilova

Förderung

  • European Union - Next Generation EU
  • Ministerstvo Zdravotnictví Ceské Republiky
  • Grantová Agentura České Republiky
  • Lékařská fakulta, Masarykova univerzita

Zitieren

APA

Kurucova, T., Reblova, K., Janovska, P., Porc, J. P., Navrkalova, V., Pavlova, S., Malcikova, J., Plevova, K., Tichy, B., Doubek, M., Bryja, V., Kotaskova, J., & Pospisilova, S. (2024). Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing. Molecular Oncology. https://doi.org/10.1002/1878-0261.13663

Vancouver

Kurucova T, Reblova K, Janovska P, Porc JP, Navrkalova V, Pavlova S, et al. Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing. Molecular Oncology. 2024. doi:10.1002/1878-0261.13663

BibTeX
@article{Kurucova2024,
  author = {Kurucova, Terezia and Reblova, Kamila and Janovska, Pavlina and Porc, Jakub Pawel and Navrkalova, Veronika and Pavlova, Sarka and Malcikova, Jitka and Plevova, Karla and Tichy, Boris and Doubek, Michael and Bryja, Vitezslav and Kotaskova, Jana and Pospisilova, Sarka},
  title = {Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13663}
}
Kostenlos starten →